A recent False Claims Act settlement has left many health-care fraud attorneys asking “what if …?” because of the paucity of federal court decisions on whether technical Stark law violations really are “fraud.”
The government’s settlement, with co-defendants Hamot Medical Center of the City of Erie and Medicor Associates, resolved whistleblower fraud allegations for $20.75 million the day before trial was scheduled to commence with jury selection (United States ex rel. Emanuele v. MedicorAssocs., E.D. Pa., No. 10-cv-245, settlement announced 11/7/17).
The settlement ended allegations that Hamot created medical directorship positions for Medicor cardiologists without the signed contracts required under the Stark physician self-referral law. In the process, however, the settlement also extinguished what health-care fraud lawyers saw as an opportunity to test the Stark law’s technical writing requirements in a trial, and see whether a jury would view violations of those requirements as fraud.
“Unfortunately, the settlement of the case deprives us of a vehicle to get a judicial ruling on whether technical writing deficiencies in meeting Stark exceptions are material for purposes of the False Claims Act,” said S. Craig Holden, a partner with Baker Donelson in Baltimore who represents health-care providers.
That sentiment was shared by Anna M. Grizzle with Bass, Berry & Sims PLC in Nashville, Tenn., who said she wasn’t surprised at the settlement on the eve of trial, which allows a provider a level of certainty about how much the litigation will cost versus the uncertainty of very significant FCA damages from a jury trial and judgment.
The litigation dealt with the complex intersection of Stark law compliance and FCA liability in the area of medical directorships, which have received a lot of attention over the years. Although providers have used medical directorships as a sham to generate referrals, asking little or nothing from the doctors involved, even legitimate directorships can lead to potential FCA liability where, as in this case, they were not adequately memorialized and updated.
Health-care attorneys were closely following the litigation to see how a jury would judge the Stark law dispute, Grizzle told me. “Absent the trial, we still don’t know how a jury would view the writing requirements,” said Grizzle, who frequently represents providers in health-care enforcement and compliance matters.
It seems that Hamot and Medicor preferred not to find out, deciding to cough up $20.8 million between them rather than risk a more expensive answer.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)